Lennox-Gastaut syndrome (LGS) is a severe and challenging-to-treat form of epilepsy. But there’s promising news for patients and caregivers seeking relief. A detailed investigation published in Frontiers in Neurology has shed light on the impact and timing of cannabidiol (CBD) treatment for LGS. The research examined data from two pivotal, Read more…
Alcohol use disorder (AUD) is a prevalent and debilitating condition, encompassing a spectrum of behaviors including addiction to alcohol. Traditional treatments for AUD include behavioral therapies and a small selection of pharmaceuticals, yet these approaches often fall short in efficacy and accessibility. Given this treatment gap, there has been growing Read more…
New research published in European Journal of Pharmacology sheds light on the therapeutic potential of cannabidiol (CBD) for heart regeneration following myocardial infarction, commonly known as a heart attack. The study, titled “Cannabidiol represses miR-143 to promote cardiomyocyte proliferation and heart regeneration after myocardial infarction”, reveals a promising mechanism through Read more…
Recent studies have examined the therapeutic benefits of cannabidiol (CBD), a non-intoxicating compound found in cannabis, especially concerning its potential influence on anxiety disorders. The research article published in Psychopharmacology delves into CBD’s effects on fear conditioning—a process critical to the development and maintenance of anxiety disorders. Researchers focused on Read more…
Cannabidiol (CBD), a non-intoxicating compound found in cannabis, has gained significant attention for its potential therapeutic effects. Notably, its impact on inflammatory processes in the context of stroke has become a focal point in medical research. A recent study, published in Experimental Neurology, sheds light on the intricate mechanisms behind Read more…
Cannabidiol (CBD), a non-psychoactive compound found in cannabis, has garnered attention for its potential health benefits in humans and pets alike. A recent study, titled “Long-term effect of oral cannabidiol administration to healthy adult dogs on tear production, intraocular pressure, and tear concentrations”, explores the impact of sustained CBD use Read more…
Researchers are initiating a landmark clinical trial to discover the potential benefits of cannabidiol (CBD) as an adjunctive therapy for individuals experiencing early psychosis. This randomized controlled trial, detailed in the study protocol, aims to assess the efficacy and safety of CBD when used alongside standard antipsychotic treatments. The trial Read more…
As the acceptance and use of cannabis and cannabinoids continue to grow, nephrologists and healthcare providers face the challenge of understanding the implications these substances have on kidney health. A comprehensive guide published by Rein, “The Nephrologist’s Guide to Cannabis and Cannabinoids”, sheds light on the intricacies of cannabis as Read more…
The study of cannabis and cannabinoids has become increasingly relevant in the medical community, especially concerning their effects on stroke patients. This comprehensive review delves into the complexities surrounding the use of these substances in the context of cerebral ischemia and stroke. It scrutinizes the controversies, risks, and promising therapeutic Read more…
The study titled “A Research Domain Criteria Approach to Gambling Disorder and Behavioral Addictions: Decision-Making, Response Inhibition, and the Role of Cannabidiol” presents a detailed analysis within the Research Domain Criteria (RDoC) framework of neuropsychiatric disorders. This pioneering approach examines the cognitive facets of gambling disorder (GD) and various behavioral Read more…